JORELIE SOINS INFIRMIERS
0779.717.078 · rovalta.com · 26/09/2026
JORELIE SOINS INFIRMIERS
Company — Judicial dissolution or nullity.
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOJORELIE SOINS INFIRMIERS is a Private limited company incorporated in 2022. Its registered office is in Charleroi.
- Legal situation
- Judicial dissolution or nullity
- BCE/KBO no. / VAT
- BE 0779.717.078
- Incorporation
- 05/01/2022
- Legal form
- Private limited company
- Registered office
- Rue Sart-les-Moulins 118-001
6044 Charleroi · WallonieSee on map - Contributed capital
- 5 000,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 4 filingsTrend over 4 financial years
| 2025 | 2024 | 2023 | 2022 | ||||
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Gross margin | 30,9 k € | +61.2% | 19,2 k € | -68.9% | 61,7 k € | -19.6% | 76,8 k € |
| EBITDA | 30,8 k € | +366% | 6,6 k € | -84.2% | 42 k € | -39.7% | 69,6 k € |
| Operating result | 6,5 k € | +137% | -17,5 k € | -180% | 21,9 k € | -68.3% | 69,2 k € |
| Net result | 817 € | +102% | -43,2 k € | -659% | 7,7 k € | -84.4% | 49,6 k € |
| Balance sheet | |||||||
| Equity | 20 k € | +4.3% | 19,1 k € | -69.3% | 62,3 k € | +14.2% | 54,6 k € |
| Total assets | 598 k € | -1.4% | 606,2 k € | -16.3% | 724,6 k € | +561% | 109,6 k € |
| Cash | – | – | 108,2 k € | +1.9% | 106,2 k € | ||
| Debts | 578 k € | -1.6% | 587,1 k € | -11.3% | 662,3 k € | +1105% | 55 k € |
Board of directors
Source · NBB, accounts to 31/12/20251 active · 4 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 05/01/2022 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months |
| Filing date | 31/08/2026 | 19/09/2025 | 19/09/2024 | 09/11/2023 |
| General meeting | 01/05/2026 | 15/09/2025 | 03/05/2024 | 05/05/2023 |
| Currency of the financial year | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 4 filingsValuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 4 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025817 €↑
- 2024Annual accounts 2024-43,2 k €↓
- 2023Annual accounts 20237,7 k €↓
- 2022Annual accounts 202249,6 k €
- 05/01/2022IncorporationPrivate limited company